SPEAKER DISCLOSURES
Download a PDF of the below Speaker Disclosures here.
Najma Ahmed Nothing relevant to disclose Joannie Allaire Nothing relevant to disclose Christopher Andrews Avir Pharma, Advisory Board; Bausch Health, Advisory Board; Knight Pharma, Advisory Board; Abbvie, Advisory Board; Sandoz, Advisory BoardnNimble Science, Research support, Advisory Board, financial interest; Alimetry Inc., Consultant, financial interest David Armstrong Canadian Association of Gastroenterology - Role 1: Past-President, Board Member, Role 2: Research Grant. Nestlé Health Sciences - Role 1: Research Grant. Weston Family Foundation - Role 1: Research Grant. Canadian Partnership Against Cancer - Role 1: Expert Advisor, Stipend. International Working Group for the Classification of Oesophagitis - Role 1: Treasurer, Board Member, Stipend; Role 2: Consensus Conference Co-Lead, Stipend. Canadian Digestive Health Foundation - Role 1: Board Member, not remunerated. World Gastroenterology Organization - Role 1: Guidelines Chair, not remunerated. Takeda Canada - Role 1: Speaker, honorarium. Viatris - Role 1: Speaker, honorarium. Fresenius Kabi - Role 1: Speaker, honorarium. AI VALI Inc - Role 1: Scientific Advisory Board, not remunerated. Cinclus Pharma - Role 1: Scientific Advisory Board, not remunerated. Phathom Pharma - Role 1: Clinical Study Advisory Board, not remunerated
Heather Armstrong Nothing relevant to disclose Marie-Claire Arrieta Nothing relevant to disclose Alan Barkun Takeda Inc., consultant and presenter Eric Benchimol 1. Hoffman La-Roche Limited and Peabody & Arnold LLP, legal consultant (for matters unrelated to vaccines or medication used to treat inflammatory bowel disease). 2. McKesson Canada, consultant. Robert Berger Medtronic: Speakers panel; Vantage: Speakers panel; Janssen: Speakers panel; Abbvie: Advisory board; Takeda: Speakers panel; Advisory board; Pfizer: Advisory board; Bioadvance: Advisory board Kirk Bergstrom Nothing relevant to disclose Charles Bernstein Advisory board or consultant to Abbvie Canada, Amgen Canada, Avir Pharmaceuticals, Bristol Myers Squibb Canada, Janssen Canada, Pfizer Canada, Sandoz Canada, Roche Canada, JAMP Canada, Takeda; Speakers fees from Abbvie Canada, Janssen Canada, Pfizer; Canadian Educational grants from Abbvie Canada, Janssen Canada, Pfizer Canada, Takeda Canada; Research grants from Abbvie Canada, Pfizer Canada, Amgen Canada, Sandoz Canada, Takeda Canada
Talat Bessissow Advisory board: Abbvie, Alimentiv, Amgen, Bristol Myers Squibb, Janssen, Pfizer, Roche, Sandoz, Takeda; Speaker: Janssen, Abbvie, Takeda, Ferring, Bristol Myers Squibb, Merck, Gilead, Viatris Jorge Bezerra Gilead - Clinical trial for children with chronic HBV infection. Grant funds paid directly to Cincinnati Children's Hospital; DX4Liver - Consultation for biomarkers of liver disease Alain Bitton Advisory Board: Janssen, Abbvie, Takeda, Hoffman Roche, Amgen, McKesson, Bristol Myers Squibb, Pfizer; Educational Activity: Fresenius Kabi, Janssen Natasha Bollegala Abbvie - speaker fees, advisory boards; Takeda - speaker fees, advisory boards; Janssen - speaker fees, advisory boards; Crohn's and Colitis Canada - research support Michael Byrne CEO and founder of Satisfai Health. Via a joint venture named ai4gi, Satisfai has a co-development agreement with Olympus America in colon polyps and artificial intelligence. Alberto Caminero Fernandez Nothing relevant to disclose Carla Coffin Grant support from Gilead Sciences, Inc., Janssen Pharmaceuticals, GSK (for the Canadian HBV Network). Advisory Board member: Altimmune Pharmaceuticals, Janssen Pharmaceuticals (for the Canadian HBV Network) Jean-Frederic Colombel Jean-Frederic Colombel has received research grants from AbbVie, Janssen Pharmaceuticals and Takeda; has received payment for lectures from AbbVie, Amgen, Allergan, Bristol-Myers Squibb Company, Ferring Pharmaceuticals, Shire, and Takeda; has received consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb Company, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Gilead, Iterative Scopes, Ipsen, Immunic, lmtbio, Inotrem, Janssen Pharmaceuticals, Landos, LimmaTech Biologics AG, Medimmune, Merck, Novartis, O Mass, Otsuka, Pfizer, Shire, Takeda, Tigenix, Viela bio; and hold stock options in Intestinal Biotech Development. Giada De Palma Nothing relevant to disclose Lee Denson Nothing relevant to disclose Levinus Dieleman I have been a consultant and/or member of Advisory Board for Janssen, Abbvie, Ferring. I have also received grant support from Janssen, Abbvie, Pfizer as well as from the Jackson GI Foundation. Kyle Flannigan Nothing relevant to disclose Jennifer Flemming Gilead - consulting on scientific conferencen planning Nauzer Forbes Boston Scientific - 1) Consultancy fees 2) Speaker's fees; Pentax Medical - 1) Consultancy fees 2) Speaker's fees 3) Research funding; Pendopharm - 1) Consultancy fees Catherine Forse Nothing relevant to disclose Jorg H. Fritz Nothing relevant to disclose Heather Galipeau Nothing relevant to disclose Jean-Eric Ghia Canadian Broad Casting/Radio-Canada: Host, writer; WebOuest: Host, writer; LaLiberté: Host, writer Véronique Giroux Nothing relevant to disclose Tanja Gonska 1) Vertex Pharmaceutical Ind: consultation 2021 and contracted for conference participation in Nov 2021; 2) Abbvie: contracted for research experiments Juan Gonzalez-Abraldes Grants: Gilead; Lecture fees: Lupin; Consulting Fees: Gilead, Genfit, Intercept, Inventiva, Boehringer-Ingelheim; None since November 2020 Karen Goodman Nothing relevant to disclose Morris Gordon Nothing relevant to disclose Leah Gramlich speaker - abbott, baxter, FK, Takeda; consultant - abbott, baxter, FK, Takeda; research funding - baxter, FK, Takeda Alex Gregorieff Nothing relevant to disclose Jennifer Halasz Nothing relevant to disclose Xiao Han Nothing relevant to disclose Jenna Haverfield Nothing relevant to disclose DeBroski Herbert Nothing relevant to disclose Simon Hirota Nothing relevant to disclose Lawrence Hookey Pendopharm Canada, speaking fees/ consultant John Igoe AbbVie- Speaker/Consultant; Janssen- Speaker/Consultant; Gilead- Speaker/Consultant; Intercept- Speaker; Merck- Consultant; Pfizer- Speaker/Consultant; Takeda- Speaker/Consultant; Lupin- Speaker/Consultant; Knight Pharmaceuticals- Speaker/Consultant Nicola Jones Nothing relevant to disclose Klaus Kaestner Nothing relevant to disclose Mohit Kehar Nothing relevant to disclose Reena Khanna RK reports fees for Consulting/Speaking from: AbbVie, Amgen, Encycle, Innomar, Gilead, Janssen, Lilly, Merck, Pendopharm, Pfizer, Roche/Genetech, Alimentiv (formerly Robarts Clinical Trials), Shire, and Takeda Canada outside the submitted work; Research fees from Roche/Genetech. Irah King Nothing relevant to disclose Narjis Kraimi Nothing relevant to disclose Peter Lakatos PLL has been a speaker and/or advisory board member: AbbVie, Amgen, Arena Pharmaceuticals, Fresenius Kabi, Genetech, Gilead, Janssen, Merck, Mylan, Organon, Pharmacosmos, Pfizer, Roche, Takeda ,Tillots and Viatris and has received unrestricted research grant: AbbVie, Gilead, Takeda and Pfizer. Adriana Lazarescu Bausch - advisory board; Knight - advisoryn board Desmond Leddin Nothing relevant to disclose Sun-Ho Lee Nothing relevant to disclose Grigorios Leontiadis Canadian Association of Gastroenterology, role 3 (volunteer work as VP Clinical Affairs) Qiaochu Liang Nothing relevant to disclose Louis Liu AbbVie, Medtronic, Lupin, Knight, Bausch Health as a speaker and consultant; Allergan as a speaker and consultant, as well as receive research funding. Donald MacIntosh Ad Board Pendopharm David Mack Nothing relevant to disclose Wallace MacNaughton Nothing relevant to disclose Karen Madsen Nothing relevant to disclose Nathalia Malacco Nothing relevant to disclose John Marshall Consultant: AbbVie, Alimentiv, Allergan, Amgen, Bausch Health, Bristol Myers Squibb, Ferring, Fresenius Kabi, Janssen, Lilly, Lupin, Novartis, Organon, Paladin, Pfizer, Pharmascience, Qu Biologics, Roche, Sandoz, Takeda, Teva, Viatris; Speaker: AbbVie, Allergan, Amgen, Ferring, Janssen, Lupin, Organon, Pfizer, Pharmascience, Roche, Takeda, Viatris Gary May Olympus - consultant; Medtronic - speaker; Vantage endoscopy - consultant; Cook Canada - consultant; Boston Scientific - consultant and speaker Jeffrey McCurdy Add-board: Pfizer, AbbVie, Takeda, Janssen, BMS, Fresenius Kabi; Speaker fees: Abbivie, Takeda, Janssen Derek McKay Nothing relevant to disclose Leanna McKenzie Nothing relevant to disclose Charles Ménard Pendopharm role 1; presenter, role 2 advisory board participant; Chess Medical: consultant; Pentax; presenter Mar Miserachs Nothing relevant to disclose Suresh Mishra Nothing relevant to disclose Tina Montreuil Nothing relevant to disclo Aleixo Muise Nothing relevant to disclose Yasmin Nasser Abbvie - Speaker fees; Allergan - advisory board member, speaker fees, clinical trial/research funding Geoffrey Nguyen Abbvie - advisory board; Takeda - advisory board Kerri Novak Kerri Novak reports advisory board fees from AbbVie, Janssen, Pfizer, Ferring, Takeda; speaker’s fees from AbbVie, Janssen, Takeda, Pfizer; and research support from AbbVie and educational support from Pfizer. Anthony Otley AbbVie - grant support, consultant, Advisory Board; Janssen - Advisory Board; Eli-Lilly- study site; Pfizer - study site, consultant John Pandolfino Torax/Ethicon: Speaking/Consulting; Takeda: Speaking; Impleo: Grant; Trimedyne- Stock Options; Alfasigma - Consulting; Endogastric Solutions - Consulting/Speaking Nathalie Perreault Nothing relevant to disclose Maria Ines Pinto-Sanchez Nothing relevant to disclose Dan Poindexter I am an employee of Oxford University Press, a non-profit academic publishing company. Véronique Pomerleau Nothing relevant to dislose Julien Pujo Nothing relevant to disclose William Rees Nothing relevant to disclose Douglas K. Rex Consultant: Olympus Corporation, Boston Scientific, Aries Pharmaceutical, Braintree Laboratories, Lumendi, Ltd., Norgine, Endokey, GI Supply, Medtronic, *Acacia Pharmaceuticals; Research Support: EndoAid, Olympus Corporation, Medivators, Erbe USA Inc, Braintree Laboratories; Shareholder: Satisfai Health Lisa Reynolds Nothing relevant to disclose David Rodrigues Nothing relevant to disclose Alaa Rostom Nothing relevant to disclose Zarwa Saqib Nothing relevant to disclose Giada Sebastiani Speaker, advisory board member: Merck, Gilead, Novartis, Novonordisk, Pfizer, Allergan, Intercept; Speaker: Abbvie, Merck, Gilead, Clinical Care Options; Unrestricted research funds: Merck, Theratec Since 2019 Cynthia Seow Advisory Boards: Janssen, Abbvie, Takeda, Ferring, Shire, Pfizer, Sandoz, Pharmascience, Fresenius Kabi, Amgen; Speaker: Janssen, Abbvie, Takeda, Ferring, Shire, Pfizer, Pharmascience; Research: Takeda Elizabeth Siciliani Nothing relevant to disclose Harminder Singh I have been on advisory board/ consulted to Amgen Canada, Bristol-Myers Squibb Canada, Sandoz Canada, Roche Canada, Takeda Canada, Pendopharm; Ferring Canada and Guardant Health Inc., Sidhartha Sinha Nothing relevant to disclose Laura Sly Nothing relevant to disclose Harry Sokol Consulting: Ferring, MSD, Enterome, BiomX; Conference: Abbvie, Novartis, Takeda, MSD, Ferring, Biocodex, Mayoly Spindler; Co-funder: Exeliom Biosciences Theodore Steiner Qu Biologics: employee (Medical Director, Infectious Diseases); Ferring: Consultant; Verity: Consultant; Avir: Consultant; Merck: Grant funding; Rebiotix, Series, Summit, Edesa: Clinical trial funding; Bold Therapeutics: research funding (Mitacs) Michael Stewart Consultant: Abbvie, Takeda, Janssen, Pfizer, Sandoz, Amgen. Speaker: Abbvie, Janssen, Amgen. Research: Takeda, Abbvie, Janssen, Genentech, Gilead. Mark Swain Advisory board: Gilead, Intercept, Novartis nSpeaker: Gilead, Intercept, AbbottnClinical trial or research support: Gilead, BMS, CymaBay, Intercept, Genfit, Pfizer, Novartis, Astra Zeneca, GSK, Celgene, Novo Nordisk, Axcella Health Inc., Merck, Galectin Therapeutics Lee-Hwa Tai Nothing relevant to disclose Laura Targownik Amgen: advisory board; Abbvie: advisory board; Janssen: advisory board; Takeda: study support, advisory board, educational material; Pfizer: study support, advisory board, authorship team; Sandoz: study support, advisory board; Celltrion: advisory board Jennifer Telford Pendopharm, advisory board member Carolina Tropini Nothing relevant to disclose Justine Turner Research funding Baxter; Research funding Vetanda Williams Turpin Nothing relevant to disclose Sander Veldhuyzen van Zanten Nothing relevant to disclose Elena Verdu Biocodex: Scientific Advisory Board, grant recipient; Gilead: grant recipient; CCC: grant recipient; Kalioppe: grant recipient Catharine Walsh Nothing relevant to disclose Kevin Waschke Pendopharm- speaker Adam Weizman Abbvie: advisory board, speaker; Janssen: advisory board, speaker; Takeda: advisory board; Novartis: advisory board Chadwick Williams Abbvie - speaker's bureau, advisory board member, lecturer; Janssen - speaker's bureau, advisory board member, lecturer; Pfizer -speaker's bureau, advisory board member; Takeda - speaker's bureau, advisory board member, lecturer Brian Yan Abbvie - Consulting honorarium; Takeda - Consulting honorarium; Janssen - Consulting honorarium; Pharmascience - Consulting honorarium; CAG - Honorarium; Royal College of Physicians and Surgeons of Canada - Honorarium
| Najma Ahmed | Nothing relevant to disclose |
|---|---|
| Joannie Allaire | Nothing relevant to disclose |
| Christopher Andrews | Avir Pharma, Advisory Board; Bausch Health, Advisory Board; Knight Pharma, Advisory Board; Abbvie, Advisory Board; Sandoz, Advisory BoardnNimble Science, Research support, Advisory Board, financial interest; Alimetry Inc., Consultant, financial interest |
| David Armstrong | Canadian Association of Gastroenterology - Role 1: Past-President, Board Member, Role 2: Research Grant. Nestlé Health Sciences - Role 1: Research Grant. Weston Family Foundation - Role 1: Research Grant. Canadian Partnership Against Cancer - Role 1: Expert Advisor, Stipend. International Working Group for the Classification of Oesophagitis - Role 1: Treasurer, Board Member, Stipend; Role 2: Consensus Conference Co-Lead, Stipend. Canadian Digestive Health Foundation - Role 1: Board Member, not remunerated. World Gastroenterology Organization - Role 1: Guidelines Chair, not remunerated. Takeda Canada - Role 1: Speaker, honorarium. Viatris - Role 1: Speaker, honorarium. Fresenius Kabi - Role 1: Speaker, honorarium. AI VALI Inc - Role 1: Scientific Advisory Board, not remunerated. Cinclus Pharma - Role 1: Scientific Advisory Board, not remunerated. Phathom Pharma - Role 1: Clinical Study Advisory Board, not remunerated |
| Heather Armstrong | Nothing relevant to disclose |
| Marie-Claire Arrieta | Nothing relevant to disclose |
| Alan Barkun | Takeda Inc., consultant and presenter |
| Eric Benchimol | 1. Hoffman La-Roche Limited and Peabody & Arnold LLP, legal consultant (for matters unrelated to vaccines or medication used to treat inflammatory bowel disease). 2. McKesson Canada, consultant. |
| Robert Berger | Medtronic: Speakers panel; Vantage: Speakers panel; Janssen: Speakers panel; Abbvie: Advisory board; Takeda: Speakers panel; Advisory board; Pfizer: Advisory board; Bioadvance: Advisory board |
| Kirk Bergstrom | Nothing relevant to disclose |
| Charles Bernstein | Advisory board or consultant to Abbvie Canada, Amgen Canada, Avir Pharmaceuticals, Bristol Myers Squibb Canada, Janssen Canada, Pfizer Canada, Sandoz Canada, Roche Canada, JAMP Canada, Takeda; Speakers fees from Abbvie Canada, Janssen Canada, Pfizer; Canadian Educational grants from Abbvie Canada, Janssen Canada, Pfizer Canada, Takeda Canada; Research grants from Abbvie Canada, Pfizer Canada, Amgen Canada, Sandoz Canada, Takeda Canada |
| Talat Bessissow | Advisory board: Abbvie, Alimentiv, Amgen, Bristol Myers Squibb, Janssen, Pfizer, Roche, Sandoz, Takeda; Speaker: Janssen, Abbvie, Takeda, Ferring, Bristol Myers Squibb, Merck, Gilead, Viatris |
| Jorge Bezerra | Gilead - Clinical trial for children with chronic HBV infection. Grant funds paid directly to Cincinnati Children's Hospital; DX4Liver - Consultation for biomarkers of liver disease |
| Alain Bitton | Advisory Board: Janssen, Abbvie, Takeda, Hoffman Roche, Amgen, McKesson, Bristol Myers Squibb, Pfizer; Educational Activity: Fresenius Kabi, Janssen |
| Natasha Bollegala | Abbvie - speaker fees, advisory boards; Takeda - speaker fees, advisory boards; Janssen - speaker fees, advisory boards; Crohn's and Colitis Canada - research support |
| Michael Byrne | CEO and founder of Satisfai Health. Via a joint venture named ai4gi, Satisfai has a co-development agreement with Olympus America in colon polyps and artificial intelligence. |
| Alberto Caminero Fernandez | Nothing relevant to disclose |
| Carla Coffin | Grant support from Gilead Sciences, Inc., Janssen Pharmaceuticals, GSK (for the Canadian HBV Network). Advisory Board member: Altimmune Pharmaceuticals, Janssen Pharmaceuticals (for the Canadian HBV Network) |
| Jean-Frederic Colombel | Jean-Frederic Colombel has received research grants from AbbVie, Janssen Pharmaceuticals and Takeda; has received payment for lectures from AbbVie, Amgen, Allergan, Bristol-Myers Squibb Company, Ferring Pharmaceuticals, Shire, and Takeda; has received consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb Company, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Gilead, Iterative Scopes, Ipsen, Immunic, lmtbio, Inotrem, Janssen Pharmaceuticals, Landos, LimmaTech Biologics AG, Medimmune, Merck, Novartis, O Mass, Otsuka, Pfizer, Shire, Takeda, Tigenix, Viela bio; and hold stock options in Intestinal Biotech Development. |
| Giada De Palma | Nothing relevant to disclose |
| Lee Denson | Nothing relevant to disclose |
| Levinus Dieleman | I have been a consultant and/or member of Advisory Board for Janssen, Abbvie, Ferring. I have also received grant support from Janssen, Abbvie, Pfizer as well as from the Jackson GI Foundation. |
| Kyle Flannigan | Nothing relevant to disclose |
| Jennifer Flemming | Gilead - consulting on scientific conferencen planning |
| Nauzer Forbes | Boston Scientific - 1) Consultancy fees 2) Speaker's fees; Pentax Medical - 1) Consultancy fees 2) Speaker's fees 3) Research funding; Pendopharm - 1) Consultancy fees |
| Catherine Forse | Nothing relevant to disclose |
| Jorg H. Fritz | Nothing relevant to disclose |
| Heather Galipeau | Nothing relevant to disclose |
| Jean-Eric Ghia | Canadian Broad Casting/Radio-Canada: Host, writer; WebOuest: Host, writer; LaLiberté: Host, writer |
| Véronique Giroux | Nothing relevant to disclose |
| Tanja Gonska | 1) Vertex Pharmaceutical Ind: consultation 2021 and contracted for conference participation in Nov 2021; 2) Abbvie: contracted for research experiments |
| Juan Gonzalez-Abraldes | Grants: Gilead; Lecture fees: Lupin; Consulting Fees: Gilead, Genfit, Intercept, Inventiva, Boehringer-Ingelheim; None since November 2020 |
| Karen Goodman | Nothing relevant to disclose |
| Morris Gordon | Nothing relevant to disclose |
| Leah Gramlich | speaker - abbott, baxter, FK, Takeda; consultant - abbott, baxter, FK, Takeda; research funding - baxter, FK, Takeda |
| Alex Gregorieff | Nothing relevant to disclose |
| Jennifer Halasz | Nothing relevant to disclose |
| Xiao Han | Nothing relevant to disclose |
| Jenna Haverfield | Nothing relevant to disclose |
| DeBroski Herbert | Nothing relevant to disclose |
| Simon Hirota | Nothing relevant to disclose |
| Lawrence Hookey | Pendopharm Canada, speaking fees/ consultant |
| John Igoe | AbbVie- Speaker/Consultant; Janssen- Speaker/Consultant; Gilead- Speaker/Consultant; Intercept- Speaker; Merck- Consultant; Pfizer- Speaker/Consultant; Takeda- Speaker/Consultant; Lupin- Speaker/Consultant; Knight Pharmaceuticals- Speaker/Consultant |
| Nicola Jones | Nothing relevant to disclose |
| Klaus Kaestner | Nothing relevant to disclose |
| Mohit Kehar | Nothing relevant to disclose |
| Reena Khanna | RK reports fees for Consulting/Speaking from: AbbVie, Amgen, Encycle, Innomar, Gilead, Janssen, Lilly, Merck, Pendopharm, Pfizer, Roche/Genetech, Alimentiv (formerly Robarts Clinical Trials), Shire, and Takeda Canada outside the submitted work; Research fees from Roche/Genetech. |
| Irah King | Nothing relevant to disclose |
| Narjis Kraimi | Nothing relevant to disclose |
| Peter Lakatos | PLL has been a speaker and/or advisory board member: AbbVie, Amgen, Arena Pharmaceuticals, Fresenius Kabi, Genetech, Gilead, Janssen, Merck, Mylan, Organon, Pharmacosmos, Pfizer, Roche, Takeda ,Tillots and Viatris and has received unrestricted research grant: AbbVie, Gilead, Takeda and Pfizer. |
| Adriana Lazarescu | Bausch - advisory board; Knight - advisoryn board |
| Desmond Leddin | Nothing relevant to disclose |
| Sun-Ho Lee | Nothing relevant to disclose |
| Grigorios Leontiadis | Canadian Association of Gastroenterology, role 3 (volunteer work as VP Clinical Affairs) |
| Qiaochu Liang | Nothing relevant to disclose |
| Louis Liu | AbbVie, Medtronic, Lupin, Knight, Bausch Health as a speaker and consultant; Allergan as a speaker and consultant, as well as receive research funding. |
| Donald MacIntosh | Ad Board Pendopharm |
| David Mack | Nothing relevant to disclose |
| Wallace MacNaughton | Nothing relevant to disclose |
| Karen Madsen | Nothing relevant to disclose |
| Nathalia Malacco | Nothing relevant to disclose |
| John Marshall | Consultant: AbbVie, Alimentiv, Allergan, Amgen, Bausch Health, Bristol Myers Squibb, Ferring, Fresenius Kabi, Janssen, Lilly, Lupin, Novartis, Organon, Paladin, Pfizer, Pharmascience, Qu Biologics, Roche, Sandoz, Takeda, Teva, Viatris; Speaker: AbbVie, Allergan, Amgen, Ferring, Janssen, Lupin, Organon, Pfizer, Pharmascience, Roche, Takeda, Viatris |
| Gary May | Olympus - consultant; Medtronic - speaker; Vantage endoscopy - consultant; Cook Canada - consultant; Boston Scientific - consultant and speaker |
| Jeffrey McCurdy | Add-board: Pfizer, AbbVie, Takeda, Janssen, BMS, Fresenius Kabi; Speaker fees: Abbivie, Takeda, Janssen |
| Derek McKay | Nothing relevant to disclose |
| Leanna McKenzie | Nothing relevant to disclose |
| Charles Ménard | Pendopharm role 1; presenter, role 2 advisory board participant; Chess Medical: consultant; Pentax; presenter |
| Mar Miserachs | Nothing relevant to disclose |
| Suresh Mishra | Nothing relevant to disclose |
| Tina Montreuil | Nothing relevant to disclo |
| Aleixo Muise | Nothing relevant to disclose |
| Yasmin Nasser | Abbvie - Speaker fees; Allergan - advisory board member, speaker fees, clinical trial/research funding |
| Geoffrey Nguyen | Abbvie - advisory board; Takeda - advisory board |
| Kerri Novak | Kerri Novak reports advisory board fees from AbbVie, Janssen, Pfizer, Ferring, Takeda; speaker’s fees from AbbVie, Janssen, Takeda, Pfizer; and research support from AbbVie and educational support from Pfizer. |
| Anthony Otley | AbbVie - grant support, consultant, Advisory Board; Janssen - Advisory Board; Eli-Lilly- study site; Pfizer - study site, consultant |
| John Pandolfino | Torax/Ethicon: Speaking/Consulting; Takeda: Speaking; Impleo: Grant; Trimedyne- Stock Options; Alfasigma - Consulting; Endogastric Solutions - Consulting/Speaking |
| Nathalie Perreault | Nothing relevant to disclose |
| Maria Ines Pinto-Sanchez | Nothing relevant to disclose |
| Dan Poindexter | I am an employee of Oxford University Press, a non-profit academic publishing company. |
| Véronique Pomerleau | Nothing relevant to dislose |
| Julien Pujo | Nothing relevant to disclose |
| William Rees | Nothing relevant to disclose |
| Douglas K. Rex | Consultant: Olympus Corporation, Boston Scientific, Aries Pharmaceutical, Braintree Laboratories, Lumendi, Ltd., Norgine, Endokey, GI Supply, Medtronic, *Acacia Pharmaceuticals; Research Support: EndoAid, Olympus Corporation, Medivators, Erbe USA Inc, Braintree Laboratories; Shareholder: Satisfai Health |
| Lisa Reynolds | Nothing relevant to disclose |
| David Rodrigues | Nothing relevant to disclose |
| Alaa Rostom | Nothing relevant to disclose |
| Zarwa Saqib | Nothing relevant to disclose |
| Giada Sebastiani | Speaker, advisory board member: Merck, Gilead, Novartis, Novonordisk, Pfizer, Allergan, Intercept; Speaker: Abbvie, Merck, Gilead, Clinical Care Options; Unrestricted research funds: Merck, Theratec Since 2019 |
| Cynthia Seow | Advisory Boards: Janssen, Abbvie, Takeda, Ferring, Shire, Pfizer, Sandoz, Pharmascience, Fresenius Kabi, Amgen; Speaker: Janssen, Abbvie, Takeda, Ferring, Shire, Pfizer, Pharmascience; Research: Takeda |
| Elizabeth Siciliani | Nothing relevant to disclose |
| Harminder Singh | I have been on advisory board/ consulted to Amgen Canada, Bristol-Myers Squibb Canada, Sandoz Canada, Roche Canada, Takeda Canada, Pendopharm; Ferring Canada and Guardant Health Inc., |
| Sidhartha Sinha | Nothing relevant to disclose |
| Laura Sly | Nothing relevant to disclose |
| Harry Sokol | Consulting: Ferring, MSD, Enterome, BiomX; Conference: Abbvie, Novartis, Takeda, MSD, Ferring, Biocodex, Mayoly Spindler; Co-funder: Exeliom Biosciences |
| Theodore Steiner | Qu Biologics: employee (Medical Director, Infectious Diseases); Ferring: Consultant; Verity: Consultant; Avir: Consultant; Merck: Grant funding; Rebiotix, Series, Summit, Edesa: Clinical trial funding; Bold Therapeutics: research funding (Mitacs) |
| Michael Stewart | Consultant: Abbvie, Takeda, Janssen, Pfizer, Sandoz, Amgen. Speaker: Abbvie, Janssen, Amgen. Research: Takeda, Abbvie, Janssen, Genentech, Gilead. |
| Mark Swain | Advisory board: Gilead, Intercept, Novartis nSpeaker: Gilead, Intercept, AbbottnClinical trial or research support: Gilead, BMS, CymaBay, Intercept, Genfit, Pfizer, Novartis, Astra Zeneca, GSK, Celgene, Novo Nordisk, Axcella Health Inc., Merck, Galectin Therapeutics |
| Lee-Hwa Tai | Nothing relevant to disclose |
| Laura Targownik | Amgen: advisory board; Abbvie: advisory board; Janssen: advisory board; Takeda: study support, advisory board, educational material; Pfizer: study support, advisory board, authorship team; Sandoz: study support, advisory board; Celltrion: advisory board |
| Jennifer Telford | Pendopharm, advisory board member |
| Carolina Tropini | Nothing relevant to disclose |
| Justine Turner | Research funding Baxter; Research funding Vetanda |
| Williams Turpin | Nothing relevant to disclose |
| Sander Veldhuyzen van Zanten | Nothing relevant to disclose |
| Elena Verdu | Biocodex: Scientific Advisory Board, grant recipient; Gilead: grant recipient; CCC: grant recipient; Kalioppe: grant recipient |
| Catharine Walsh | Nothing relevant to disclose |
| Kevin Waschke | Pendopharm- speaker |
| Adam Weizman | Abbvie: advisory board, speaker; Janssen: advisory board, speaker; Takeda: advisory board; Novartis: advisory board |
| Chadwick Williams | Abbvie - speaker's bureau, advisory board member, lecturer; Janssen - speaker's bureau, advisory board member, lecturer; Pfizer -speaker's bureau, advisory board member; Takeda - speaker's bureau, advisory board member, lecturer |
| Brian Yan | Abbvie - Consulting honorarium; Takeda - Consulting honorarium; Janssen - Consulting honorarium; Pharmascience - Consulting honorarium; CAG - Honorarium; Royal College of Physicians and Surgeons of Canada - Honorarium |